von Willebrand disease: advances in pathogenetic understanding, diagnosis, and therapy

No increase in bleeding identified in type 1 VWD subjects with D1472H sequence variation

(2013) V. H. Flood et al.   BLOOD

Alloantibodies in von Willebrand disease

(2013) P. D. James et al.   BLOOD

Analysis of the storage and secretion of von Willebrand factor in blood outgrowth endothelial cells derived from patients with von Willebrand disease

(2013) J.-W. Wang et al.   BLOOD

The C-type lectin receptor CLEC4M binds, internalizes, and clears von Willebrand factor and contributes to the variation in plasma von Willebrand factor levels

(2013) N. Rydz et al.   BLOOD

Pharmacokinetics and safety of a novel recombinant human von Willebrand factor manufactured with a plasma-free method: a prospective clinical trial

(2013) P. M. Mannucci et al.   BLOOD

Cellular and molecular basis of von Willebrand disease: studies on blood outgrowth endothelial cells

(2013) R. D. Starke et al.   BLOOD

Principles of care for the diagnosis and treatment of von Willebrand disease

(2013) G. Castaman et al.   HAEMATOLOGICA

The genetics of Canadian type 3 von Willebrand disease: further evidence for co-dominant inheritance of mutant alleles

(2013) M. Bowman et al.   JOURNAL OF THROMBOSIS AND HAEMOSTASIS

Intersection of mechanisms of type 2A VWD through defects in VWF multimerization, secretion, ADAMTS-13 susceptibility, and regulated storage

(2012) P. M. Jacobi et al.   BLOOD

Sequence and structure relationships within von Willebrand factor

(2012) Y.-F. Zhou et al.   BLOOD

A comparative evaluation of a new automated assay for von Willebrand factor activity

(2012) A. S. Lawrie et al.   HAEMOPHILIA

Critical von Willebrand factor A1 domain residues influence type VI collagen binding

(2012) V. H. FLOOD et al.   JOURNAL OF THROMBOSIS AND HAEMOSTASIS

Use of a mouse model to elucidate the phenotypic effects of the von Willebrand factor cleavage mutants, Y1605A/M1606A and R1597W

(2012) C. M. PRUSS et al.   JOURNAL OF THROMBOSIS AND HAEMOSTASIS

Comparison of type I, type III and type VI collagen binding assays in diagnosis of von Willebrand disease

(2012) V. H. FLOOD et al.   JOURNAL OF THROMBOSIS AND HAEMOSTASIS

VWF mutations and new sequence variations identified in healthy controls are more frequent in the African-American population

(2011) D. B. Bellissimo et al.   BLOOD

Mutation-specific hemostatic variability in mice expressing common type 2B von Willebrand disease substitutions

(2010) M. Golder et al.   BLOOD

Mutation and ADAMTS13-dependent modulation of disease severity in a mouse model for von Willebrand disease type 2B

(2010) J. Rayes et al.   BLOOD

Functional characterization of a 13-bp deletion (c.-1522_-1510del13) in the promoter of the von Willebrand factor gene in type 1 von Willebrand disease

(2010) M. Othman et al.   BLOOD

Gain-of-function GPIb ELISA assay for VWF activity in the Zimmerman Program for the Molecular and Clinical Biology of VWD

(2010) V. H. Flood et al.   BLOOD

Common VWF exon 28 polymorphisms in African Americans affecting the VWF activity assay by ristocetin cofactor

(2010) V. H. Flood et al.   BLOOD

Novel Associations of Multiple Genetic Loci With Plasma Levels of Factor VII, Factor VIII, and von Willebrand Factor

(2010) Nicholas L. Smith et al.   CIRCULATION

Characterization of W1745C and S1783A: 2 novel mutations causing defective collagen binding in the A3 domain of von Willebrand factor

(2009) A. F. Riddell et al.   BLOOD

How I treat von Willebrand disease

(2009) F. Rodeghiero et al.   BLOOD

Expression of 14 von Willebrand factor mutations identified in patients with type 1 von Willebrand disease from the MCMDM-1VWD study

(2009) J. EIKENBOOM et al.   JOURNAL OF THROMBOSIS AND HAEMOSTASIS

The prevalence of symptomatic von Willebrand disease in primary care practice

(2009) M. BOWMAN et al.   JOURNAL OF THROMBOSIS AND HAEMOSTASIS

Identification of type 1 von Willebrand disease patients with reduced von Willebrand factor survival by assay of the VWF propeptide in the European study: Molecular and Clinical Markers for the Diagnosis and Management of Type 1 VWD (MCMDM-1VWD)

(2008) S. L. Haberichter et al.   BLOOD

Clinical and molecular predictors of thrombocytopenia and risk of bleeding in patients with von Willebrand disease type 2B: a cohort study of 67 patients

(2008) A. B. Federici et al.   BLOOD

Prophylaxis in von Willebrand disease

(2008) E. BERNTORP   HAEMOPHILIA

Generation and validation of the Condensed MCMDM-1VWD Bleeding Questionnaire for von Willebrand disease

(2008) M. BOWMAN et al.   JOURNAL OF THROMBOSIS AND HAEMOSTASIS